You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study
|
|---|---|
| Published in |
Arthritis Research & Therapy, June 2011
|
| DOI | 10.1186/ar3369 |
| Pubmed ID | |
| Authors |
Suzanne Arends, Elisabeth Brouwer, Eveline van der Veer, Henk Groen, Martha K Leijsma, Pieternella M Houtman, Tim L Th A Jansen, Cees GM Kallenberg, Anneke Spoorenberg |
| Abstract |
Identifying ankylosing spondylitis (AS) patients who are likely to benefit from tumor necrosis factor-alpha (TNF-α) blocking therapy is important, especially in view of the costs and potential side effects of these agents. Recently, the AS Disease Activity Score (ASDAS) has been developed to assess both subjective and objective aspects of AS disease activity. However, data about the predictive value of the ASDAS with respect to clinical response to TNF-α blocking therapy are lacking. The aim of the present study was to identify baseline predictors of response and discontinuation of TNF-α blocking therapy in AS patients in daily clinical practice. |
Mendeley readers
The data shown below were compiled from readership statistics for 121 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 1 | <1% |
| Australia | 1 | <1% |
| Finland | 1 | <1% |
| Paraguay | 1 | <1% |
| Denmark | 1 | <1% |
| Spain | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 114 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 21 | 17% |
| Other | 14 | 12% |
| Student > Ph. D. Student | 14 | 12% |
| Researcher | 8 | 7% |
| Student > Doctoral Student | 8 | 7% |
| Other | 27 | 22% |
| Unknown | 29 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 49 | 40% |
| Immunology and Microbiology | 7 | 6% |
| Nursing and Health Professions | 6 | 5% |
| Agricultural and Biological Sciences | 4 | 3% |
| Neuroscience | 4 | 3% |
| Other | 17 | 14% |
| Unknown | 34 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 March 2019.
All research outputs
#7,356,343
of 25,374,917 outputs
Outputs from Arthritis Research & Therapy
#1,510
of 3,381 outputs
Outputs of similar age
#39,791
of 126,624 outputs
Outputs of similar age from Arthritis Research & Therapy
#19
of 42 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 3,381 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one has gotten more attention than average, scoring higher than 53% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 126,624 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.